Minsig Choi - Concepedia

Author

Minsig Choi

The Barbara Ann Karmanos Cancer Institute

Also Known As

Choi, Minsig, Hyang-Sook Kim, M. Choi, Minsig Choi

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

The Barbara Ann Karmanos Cancer Institute Wayne State University University of Michigan University of Colorado Denver Texas Oncology

About

Minsig Choi is an author at The Barbara Ann Karmanos Cancer Institute specializing in oncology, medicine, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	724
2	Health Sciences	3	3	390
3	Hepatology	2	2	515
4	Public Health	1	1	33
5	Health Informatics	1	1	33

Minsig Choi

Publications

Citations

H-Index

Page 1

	Year	Citations
Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial Josep M. Llovet, Masatoshi Kudo, Philippe Merle, The Lancet Oncology OncologyHepatologyMedicineClinical TrialsPembrolizumab Versus Lenvatinib	2023	364
Durvalumab with or without bevacizumab with transarterial chemoembolisation in hepatocellular carcinoma (EMERALD-1): a multiregional, randomised, double-blind, placebo-controlled, phase 3 study Bruno Sangro, Masatoshi Kudo, Joseph P. Erinjeri, The Lancet HepatologyTransarterial ChemoembolisationMedicinePharmacologyPathology	2025	151
A randomized, phase II trial of cetuximab with or without PX-866, an irreversible oral phosphatidylinositol 3-kinase inhibitor, in patients with relapsed or metastatic head and neck squamous cell cancer Antonio Jimeno, Keisuke Shirai, Minsig Choi, Annals of Oncology Ii TrialMedicinePharmacologyPathologyHead And Neck Cancer	2014	98
Using 18F-Fluorodeoxyglucose Positron Emission Tomography to Monitor Clinical Outcomes in Patients Treated With Neoadjuvant Chemo-Radiotherapy for Locally Advanced Pancreatic Cancer Minsig Choi, Lance K. Heilbrun, Raghu Venkatramanamoorthy, American Journal of Clinical Oncology	2010	91
Direct therapeutic targeting of immune checkpoint PD-1 in pancreatic cancer Mei Gao, Miranda Lin, Richard A. Moffitt, British Journal of Cancer	2018	54
Network Modeling of MDM2 Inhibitor-Oxaliplatin Combination Reveals Biological Synergy in wt-p53 solid tumors Asfar S. Azmi, Sanjeev Banerjee, Shadan Ali, Oncotarget	2011	48
A Randomized, Phase II Trial of Cetuximab With or Without PX-866, an Irreversible Oral Phosphatidylinositol 3-Kinase Inhibitor, in Patients With Metastatic Colorectal Carcinoma Daniel W. Bowles, Mark D. Kochenderfer, Allen Lee Cohn, Clinical Colorectal Cancer OncologyPhase Ii TrialMedicineMetastatic Colorectal CarcinomaPathology	2016	42
Surveillance and Monitoring of Adult Cancer Survivors Minsig Choi, Barbara S. Craft, Stephen A. Geraci The American Journal of Medicine Health InformaticsCancer EpidemiologyMedicineEpidemiology Of CancerCancer Registration	2011	33
Ipilimumab augments antitumor activity of bispecific antibody-armed T cells Hiroshi Yano, Archana Thakur, Elyse N. Tomaszewski, Journal of Translational Medicine	2014	32
Preclinical Studies of Apogossypolone, a Novel Pan Inhibitor of Bcl-2 and Mcl-1, Synergistically Potentiates Cytotoxic Effect of Gemcitabine in Pancreatic Cancer Cells Sanjeev Banerjee, Minsig Choi, Amro Aboukameel, Pancreas	2010	26

Page 1